MedKoo Cat#: 527673 | Name: PU139
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PU139 is a novel histone acetyltransferase (HAT) inhibitor.

Chemical Structure

PU139
PU139
CAS#158093-65-3

Theoretical Analysis

MedKoo Cat#: 527673

Name: PU139

CAS#: 158093-65-3

Chemical Formula: C12H7FN2OS

Exact Mass: 246.0263

Molecular Weight: 246.26

Elemental Analysis: C, 58.53; H, 2.87; F, 7.71; N, 11.38; O, 6.50; S, 13.02

Price and Availability

Size Price Availability Quantity
5mg USD 450.00 2 Weeks
10mg USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
PU139; PU-139; PU 139
IUPAC/Chemical Name
2-(4-Fluorophenyl)isothiazolo[5,4-b]pyridin-3(2H)-one
InChi Key
QMCIVCACYJRAAY-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H7FN2OS/c13-8-3-5-9(6-4-8)15-12(16)10-2-1-7-14-11(10)17-15/h1-7H
SMILES Code
O=C1N(C2=CC=C(F)C=C2)SC3=NC=CC=C31
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Certificate of Analysis
Safety Data Sheet (SDS)

Preparing Stock Solutions

The following data is based on the product molecular weight 246.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cheng Y, Ning K, Chen Y, Hou C, Yu H, Yu H, Chen S, Guo X, Dong L. Identification of histone acetyltransferase genes responsible for cannabinoid synthesis in hemp. Chin Med. 2023 Feb 13;18(1):16. doi: 10.1186/s13020-023-00720-0. PMID: 36782242; PMCID: PMC9926835. 2: Ramakrishnan J, Magudeeswaran S, Suresh S, Poomani K. Investigation of intermolecular interactions and binding mechanism of PU139 and PU141 molecules with p300 HAT enzyme via molecular docking, molecular dynamics simulations and binding free energy analysis. J Biomol Struct Dyn. 2023 Mar;41(4):1351-1365. doi: 10.1080/07391102.2021.2020164. Epub 2022 Jan 3. PMID: 34974819. 3: Gajer JM, Furdas SD, Gründer A, Gothwal M, Heinicke U, Keller K, Colland F, Fulda S, Pahl HL, Fichtner I, Sippl W, Jung M. Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo. Oncogenesis. 2015 Feb 9;4(2):e137. doi: 10.1038/oncsis.2014.51. PMID: 25664930; PMCID: PMC4338425. 4: Carneiro VC, de Abreu da Silva IC, Torres EJ, Caby S, Lancelot J, Vanderstraete M, Furdas SD, Jung M, Pierce RJ, Fantappié MR. Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis. PLoS Pathog. 2014 May 8;10(5):e1004116. doi: 10.1371/journal.ppat.1004116. PMID: 24809504; PMCID: PMC4014452.